[{"Assets_0_Q2_USD":1024131000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-110227000.0,"NetIncomeLoss_1_Q2_USD":-35053000.0,"NetIncomeLoss_2_Q2_USD":-65354000.0,"StockholdersEquity_0_Q2_USD":360167000.0,"Ticker":"TLRY","CIK":"1731348","name":"TILRAY, INC.","OfficialName":"Tilray Brands Inc. Class 2 Common Stock ","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2601094383.0","Country":"Canada","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190813"}]